Can Ionis Pharmaceuticals Stock See A Rebound After Falling 28% YTD?
- Tuesday, April 20, 2021, 7:10
- Market
- Add a comment
We believe that Ionis Pharmaceuticals stock, a biotech company that specializes in discovering and developing RNA-targeted therapeutics, is a good buying opportunity at the present time. IONS stock trades near $41 currently and it is, in fact, down 34% from its pre-Covid high of around $62…
About the Author
admin123 has written 23544 stories on this site.
